Skip to main content
Erschienen in: Current Diabetes Reports 12/2015

01.12.2015 | Microvascular Complications—Retinopathy (JK Sun, Section Editor)

Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy

verfasst von: David J. Ramsey, G. B. Arden

Erschienen in: Current Diabetes Reports | Ausgabe 12/2015

Einloggen, um Zugang zu erhalten

Abstract

In diabetes, retinal blood flow is compromised, and retinal hypoxia is likely to be further intensified during periods of darkness. During dark adaptation, rod photoreceptors in the outer retina are maximally depolarized and continuously release large amounts of the neurotransmitter glutamate—an energetically demanding process that requires the highest oxygen consumption per unit volume of any tissue of the body. In complete darkness, even more oxygen is consumed by the outer retina, producing a steep fall in the retinal oxygen tension curve which reaches a nadir at the depth of the mitochondrial-rich rod inner segments. In contrast to the normal retina, the diabetic retina cannot meet the added metabolic load imposed by the dark-adapted rod photoreceptors; this exacerbates retinal hypoxia and stimulates the overproduction of vascular endothelial growth factor (VEGF). The use of nocturnal illumination to prevent dark adaptation, specifically reducing the rod photoreceptor dark current, should ameliorate diabetic retinopathy.
Literatur
1.
Zurück zum Zitat CDC. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. 2011. CDC. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. 2011.
2.
Zurück zum Zitat Wong TY et al. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care. 2009;32(12):2307–13.PubMedCentralPubMedCrossRef Wong TY et al. Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis. Diabetes Care. 2009;32(12):2307–13.PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2012;8(4):228–36.CrossRef Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nat Rev Endocrinol. 2012;8(4):228–36.CrossRef
5.
Zurück zum Zitat Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early treatment diabetic retinopathy study research group. Arch Ophthalmol. 1995;113(9):1144–55. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Early treatment diabetic retinopathy study research group. Arch Ophthalmol. 1995;113(9):1144–55.
6.
Zurück zum Zitat Elman MJ et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6):1064–1077.e35.PubMedCentralPubMedCrossRef Elman MJ et al. Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology. 2010;117(6):1064–1077.e35.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Mitchell P et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615–25.PubMedCrossRef Mitchell P et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology. 2011;118(4):615–25.PubMedCrossRef
8.
Zurück zum Zitat Nguyen QD et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789–801.PubMedCrossRef Nguyen QD et al. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology. 2012;119(4):789–801.PubMedCrossRef
9.
Zurück zum Zitat Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985;103(12):1796–806. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol. 1985;103(12):1796–806.
10.
Zurück zum Zitat Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial. Arch Ophthalmol. 2007;125(3):318–24. Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial. Arch Ophthalmol. 2007;125(3):318–24.
11.
Zurück zum Zitat Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: early treatment diabetic retinopathy study report no. 3. The early treatment diabetic retinopathy study research group. Int Ophthalmol Clin. 1987;27(4):254–64. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: early treatment diabetic retinopathy study report no. 3. The early treatment diabetic retinopathy study research group. Int Ophthalmol Clin. 1987;27(4):254–64.
12.
Zurück zum Zitat Osaadon P et al. A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye (Lond). 2014;28(5):510–20.CrossRef Osaadon P et al. A review of anti-VEGF agents for proliferative diabetic retinopathy. Eye (Lond). 2014;28(5):510–20.CrossRef
14.
15.
Zurück zum Zitat Thomas BJ et al. Evolving strategies in the management of diabetic macular edema: clinical trials and current management. Can J Ophthalmol. 2013;48(1):22–30.PubMedCrossRef Thomas BJ et al. Evolving strategies in the management of diabetic macular edema: clinical trials and current management. Can J Ophthalmol. 2013;48(1):22–30.PubMedCrossRef
16.
Zurück zum Zitat Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):703–13. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):703–13.
17.
Zurück zum Zitat The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977–86. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977–86.
18.
Zurück zum Zitat Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287(19):2563–9. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287(19):2563–9.
19.
Zurück zum Zitat Klein R et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102(4):527–32.PubMedCrossRef Klein R et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102(4):527–32.PubMedCrossRef
20.
Zurück zum Zitat Klein R et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102(4):520–6.PubMedCrossRef Klein R et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102(4):520–6.PubMedCrossRef
21.
Zurück zum Zitat Aiello LP et al. Oral protein kinase c beta inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C beta Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C beta Inhibitor-Diabetic Retinopathy Study 2. Retina. 2011;31(10):2084–94.PubMedCrossRef Aiello LP et al. Oral protein kinase c beta inhibition using ruboxistaurin: efficacy, safety, and causes of vision loss among 813 patients (1,392 eyes) with diabetic retinopathy in the Protein Kinase C beta Inhibitor-Diabetic Retinopathy Study and the Protein Kinase C beta Inhibitor-Diabetic Retinopathy Study 2. Retina. 2011;31(10):2084–94.PubMedCrossRef
22.
Zurück zum Zitat Bursell SE et al. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care. 1999;22(8):1245–51.PubMedCrossRef Bursell SE et al. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care. 1999;22(8):1245–51.PubMedCrossRef
23.
Zurück zum Zitat Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Early treatment diabetic retinopathy study research group. Ophthalmology. 1991;98(5 Suppl):757–65. Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Early treatment diabetic retinopathy study research group. Ophthalmology. 1991;98(5 Suppl):757–65.
24.
Zurück zum Zitat Arden GB et al. Regression of early diabetic macular oedema is associated with prevention of dark adaptation. Eye (Lond). 2011;25(12):1546–54.CrossRef Arden GB et al. Regression of early diabetic macular oedema is associated with prevention of dark adaptation. Eye (Lond). 2011;25(12):1546–54.CrossRef
25.
Zurück zum Zitat Arden GB et al. A preliminary trial to determine whether prevention of dark adaptation affects the course of early diabetic retinopathy. Eye (Lond). 2010;24(7):1149–55.CrossRef Arden GB et al. A preliminary trial to determine whether prevention of dark adaptation affects the course of early diabetic retinopathy. Eye (Lond). 2010;24(7):1149–55.CrossRef
27.
Zurück zum Zitat Brandon C, Lam DM. L-glutamic acid: a neurotransmitter candidate for cone photoreceptors in human and rat retinas. Proc Natl Acad Sci U S A. 1983;80(16):5117–21.PubMedCentralPubMedCrossRef Brandon C, Lam DM. L-glutamic acid: a neurotransmitter candidate for cone photoreceptors in human and rat retinas. Proc Natl Acad Sci U S A. 1983;80(16):5117–21.PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Birol G et al. Oxygen distribution and consumption in the macaque retina. Am J Physiol Heart Circ Physiol. 2007;293(3):H1696–704.PubMedCrossRef Birol G et al. Oxygen distribution and consumption in the macaque retina. Am J Physiol Heart Circ Physiol. 2007;293(3):H1696–704.PubMedCrossRef
33.
Zurück zum Zitat Yu DY, Cringle SJ. Outer retinal anoxia during dark adaptation is not a general property of mammalian retinas. Comp Biochem Physiol A Mol Integr Physiol. 2002;132(1):47–52.PubMedCrossRef Yu DY, Cringle SJ. Outer retinal anoxia during dark adaptation is not a general property of mammalian retinas. Comp Biochem Physiol A Mol Integr Physiol. 2002;132(1):47–52.PubMedCrossRef
34.
Zurück zum Zitat Linsenmeier RA et al. Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci. 1998;39(9):1647–57.PubMed Linsenmeier RA et al. Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci. 1998;39(9):1647–57.PubMed
35.
Zurück zum Zitat Braun RD, Linsenmeier RA, Goldstick TK. Oxygen consumption in the inner and outer retina of the cat. Invest Ophthalmol Vis Sci. 1995;36(3):542–54.PubMed Braun RD, Linsenmeier RA, Goldstick TK. Oxygen consumption in the inner and outer retina of the cat. Invest Ophthalmol Vis Sci. 1995;36(3):542–54.PubMed
36.
Zurück zum Zitat Linsenmeier RA, Braun RD. Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia. J Gen Physiol. 1992;99(2):177–97.PubMedCrossRef Linsenmeier RA, Braun RD. Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia. J Gen Physiol. 1992;99(2):177–97.PubMedCrossRef
37.
Zurück zum Zitat Linsenmeier RA. Electrophysiological consequences of retinal hypoxia. Graefes Arch Clin Exp Ophthalmol. 1990;228(2):143–50.PubMedCrossRef Linsenmeier RA. Electrophysiological consequences of retinal hypoxia. Graefes Arch Clin Exp Ophthalmol. 1990;228(2):143–50.PubMedCrossRef
38.
Zurück zum Zitat Haugh LM, Linsenmeier RA, Goldstick TK. Mathematical models of the spatial distribution of retinal oxygen tension and consumption, including changes upon illumination. Ann Biomed Eng. 1990;18(1):19–36.PubMedCrossRef Haugh LM, Linsenmeier RA, Goldstick TK. Mathematical models of the spatial distribution of retinal oxygen tension and consumption, including changes upon illumination. Ann Biomed Eng. 1990;18(1):19–36.PubMedCrossRef
39.
Zurück zum Zitat Linsenmeier RA. Effects of light and darkness on oxygen distribution and consumption in the cat retina. J Gen Physiol. 1986;88(4):521–42.PubMedCrossRef Linsenmeier RA. Effects of light and darkness on oxygen distribution and consumption in the cat retina. J Gen Physiol. 1986;88(4):521–42.PubMedCrossRef
40.
Zurück zum Zitat Jones DP, Aw TY, Changli B, Sillau AH. Regulation of mitochondrial distribution: an adaptive response to changes in oxygen supply. In: Lahiri S, Cherniack NS, Fitzgerald RS, editors. Response and adaptation to hypoxia. New York: Springer; 1991. p. 25–35.CrossRef Jones DP, Aw TY, Changli B, Sillau AH. Regulation of mitochondrial distribution: an adaptive response to changes in oxygen supply. In: Lahiri S, Cherniack NS, Fitzgerald RS, editors. Response and adaptation to hypoxia. New York: Springer; 1991. p. 25–35.CrossRef
41.
Zurück zum Zitat Bill A, Sperber GO. Aspects of oxygen and glucose consumption in the retina: effects of high intraocular pressure and light. Graefes Arch Clin Exp Ophthalmol. 1990;228(2):124–7.PubMedCrossRef Bill A, Sperber GO. Aspects of oxygen and glucose consumption in the retina: effects of high intraocular pressure and light. Graefes Arch Clin Exp Ophthalmol. 1990;228(2):124–7.PubMedCrossRef
42.
Zurück zum Zitat Ames 3rd A et al. Light-induced increases in cGMP metabolic flux correspond with electrical responses of photoreceptors. J Biol Chem. 1986;261(28):13034–42.PubMed Ames 3rd A et al. Light-induced increases in cGMP metabolic flux correspond with electrical responses of photoreceptors. J Biol Chem. 1986;261(28):13034–42.PubMed
45.
Zurück zum Zitat McFarland RA, Evans JN. Alterations in dark adaptation under reduced oxygen tensions. Am J Physiol. 1939;127:37–50. McFarland RA, Evans JN. Alterations in dark adaptation under reduced oxygen tensions. Am J Physiol. 1939;127:37–50.
48.
Zurück zum Zitat Speiser P, Gittelsohn AM, Patz A. Studies on diabetic retinopathy. 3. Influence of diabetes on intramural pericytes. Arch Ophthalmol. 1968;80(3):332–7.PubMedCrossRef Speiser P, Gittelsohn AM, Patz A. Studies on diabetic retinopathy. 3. Influence of diabetes on intramural pericytes. Arch Ophthalmol. 1968;80(3):332–7.PubMedCrossRef
49.
Zurück zum Zitat Cogan DG, Toussaint D, Kuwabara T. Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol. 1961;66:366–78.PubMedCrossRef Cogan DG, Toussaint D, Kuwabara T. Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol. 1961;66:366–78.PubMedCrossRef
50.
Zurück zum Zitat Klein R et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology. 1995;102(1):7–16.PubMedCrossRef Klein R et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology. 1995;102(1):7–16.PubMedCrossRef
51.
Zurück zum Zitat Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie house classification. ETDRS report number 10. Early treatment diabetic retinopathy study research group. Ophthalmology. 1991;98(5 Suppl):786–806. Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie house classification. ETDRS report number 10. Early treatment diabetic retinopathy study research group. Ophthalmology. 1991;98(5 Suppl):786–806.
52.
Zurück zum Zitat Arend O et al. Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network. Br J Ophthalmol. 1991;75(9):514–8.PubMedCentralPubMedCrossRef Arend O et al. Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network. Br J Ophthalmol. 1991;75(9):514–8.PubMedCentralPubMedCrossRef
53.
Zurück zum Zitat Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13. Early treatment diabetic retinopathy study research group. Ophthalmology. 1991;98(5 Suppl):834–40. Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13. Early treatment diabetic retinopathy study research group. Ophthalmology. 1991;98(5 Suppl):834–40.
55.
Zurück zum Zitat Aiello LP. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res. 1997;29(5):354–62.PubMedCrossRef Aiello LP. Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies. Ophthalmic Res. 1997;29(5):354–62.PubMedCrossRef
56.
Zurück zum Zitat Pe’er J et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Investig. 1995;72(6):638–45.PubMed Pe’er J et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Investig. 1995;72(6):638–45.PubMed
57.
Zurück zum Zitat Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye (Lond). 2009;23(7):1496–508.CrossRef Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye (Lond). 2009;23(7):1496–508.CrossRef
58.
Zurück zum Zitat Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–25.PubMedCrossRef Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–25.PubMedCrossRef
59.
Zurück zum Zitat Kowluru R, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or galactosemia. II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy. Curr Eye Res. 1994;13(12):891–6.PubMedCrossRef Kowluru R, Kern TS, Engerman RL. Abnormalities of retinal metabolism in diabetes or galactosemia. II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy. Curr Eye Res. 1994;13(12):891–6.PubMedCrossRef
60.
Zurück zum Zitat Shweiki D et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359(6398):843–5.PubMedCrossRef Shweiki D et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 1992;359(6398):843–5.PubMedCrossRef
61.
Zurück zum Zitat Leung DW et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246(4935):1306–9.PubMedCrossRef Leung DW et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246(4935):1306–9.PubMedCrossRef
62.•
Zurück zum Zitat Xin X et al. Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4. Proc Natl Acad Sci U S A. 2013;110(36):E3425–34. This paper identifies angiopoietin-like 4 (ANGPTL4) as a cytokine up-regulated by HIF-1 in hypoxic Müller cells in vitro and the ischemic inner retina in vivo. Similar to VEGF, ANGPTL4 promotes increased vessel permeability and may be a novel and important target in DME.PubMedCentralPubMedCrossRef Xin X et al. Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4. Proc Natl Acad Sci U S A. 2013;110(36):E3425–34. This paper identifies angiopoietin-like 4 (ANGPTL4) as a cytokine up-regulated by HIF-1 in hypoxic Müller cells in vitro and the ischemic inner retina in vivo. Similar to VEGF, ANGPTL4 promotes increased vessel permeability and may be a novel and important target in DME.PubMedCentralPubMedCrossRef
63.
Zurück zum Zitat Aiello LP et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331(22):1480–7.PubMedCrossRef Aiello LP et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331(22):1480–7.PubMedCrossRef
64.
Zurück zum Zitat Mathews MK et al. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest Ophthalmol Vis Sci. 1997;38(13):2729–41.PubMed Mathews MK et al. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest Ophthalmol Vis Sci. 1997;38(13):2729–41.PubMed
65.
Zurück zum Zitat Frank RN et al. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. Arch Ophthalmol. 1997;115(8):1036–47.PubMedCrossRef Frank RN et al. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. Arch Ophthalmol. 1997;115(8):1036–47.PubMedCrossRef
66.
Zurück zum Zitat Murata T et al. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Investig. 1996;74(4):819–25.PubMed Murata T et al. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Investig. 1996;74(4):819–25.PubMed
67.
Zurück zum Zitat Ishibashi T, Tanaka K, Taniguchi Y. Platelet aggregation and coagulation in the pathogenesis of diabetic retinopathy in rats. Diabetes. 1981;30(7):601–6.PubMedCrossRef Ishibashi T, Tanaka K, Taniguchi Y. Platelet aggregation and coagulation in the pathogenesis of diabetic retinopathy in rats. Diabetes. 1981;30(7):601–6.PubMedCrossRef
68.
Zurück zum Zitat Joussen AM et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18(12):1450–2.PubMed Joussen AM et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18(12):1450–2.PubMed
70.
Zurück zum Zitat Kandarakis SA et al. Dietary glycotoxins induce RAGE and VEGF up-regulation in the retina of normal rats. Exp Eye Res. 2015;137:1–10.PubMedCrossRef Kandarakis SA et al. Dietary glycotoxins induce RAGE and VEGF up-regulation in the retina of normal rats. Exp Eye Res. 2015;137:1–10.PubMedCrossRef
71.
Zurück zum Zitat Puddu A et al. Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization. Mol Vis. 2012;18:2509–17.PubMedCentralPubMed Puddu A et al. Vascular endothelial growth factor-C secretion is increased by advanced glycation end-products: possible implication in ocular neovascularization. Mol Vis. 2012;18:2509–17.PubMedCentralPubMed
72.
73.
Zurück zum Zitat Brooks JT et al. Variations within oxygen-regulated gene expression in humans. J Appl Physiol (1985). 2009;106(1):212–20.CrossRef Brooks JT et al. Variations within oxygen-regulated gene expression in humans. J Appl Physiol (1985). 2009;106(1):212–20.CrossRef
74.
Zurück zum Zitat Marsh S et al. Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy. Diabetes Care. 2000;23(9):1375–80.PubMedCrossRef Marsh S et al. Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy. Diabetes Care. 2000;23(9):1375–80.PubMedCrossRef
75.
76.
Zurück zum Zitat Tornquist P, Alm A. Retinal and choroidal contribution to retinal metabolism in vivo. A study in pigs. Acta Physiol Scand. 1979;106(3):351–7.PubMedCrossRef Tornquist P, Alm A. Retinal and choroidal contribution to retinal metabolism in vivo. A study in pigs. Acta Physiol Scand. 1979;106(3):351–7.PubMedCrossRef
77.
Zurück zum Zitat Alm A, Bill A. The oxygen supply to the retina. II. Effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats. A study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Acta Physiol Scand. 1972;84(3):306–19.PubMedCrossRef Alm A, Bill A. The oxygen supply to the retina. II. Effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats. A study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Acta Physiol Scand. 1972;84(3):306–19.PubMedCrossRef
78.
Zurück zum Zitat Ahmed J et al. Oxygen distribution in the macaque retina. Invest Ophthalmol Vis Sci. 1993;34(3):516–21.PubMed Ahmed J et al. Oxygen distribution in the macaque retina. Invest Ophthalmol Vis Sci. 1993;34(3):516–21.PubMed
79.
Zurück zum Zitat Cringle SJ et al. Light and choroidal PO2 modulation of intraretinal oxygen levels in an avascular retina. Invest Ophthalmol Vis Sci. 1999;40(10):2307–13.PubMed Cringle SJ et al. Light and choroidal PO2 modulation of intraretinal oxygen levels in an avascular retina. Invest Ophthalmol Vis Sci. 1999;40(10):2307–13.PubMed
80.
Zurück zum Zitat Tillis TN et al. Preretinal oxygen changes in the rabbit under conditions of light and dark. Invest Ophthalmol Vis Sci. 1988;29(6):988–91.PubMed Tillis TN et al. Preretinal oxygen changes in the rabbit under conditions of light and dark. Invest Ophthalmol Vis Sci. 1988;29(6):988–91.PubMed
81.
Zurück zum Zitat Stefansson E. Retinal oxygen tension is higher in light than dark. Pediatr Res. 1988;23(1):5–8.PubMedCrossRef Stefansson E. Retinal oxygen tension is higher in light than dark. Pediatr Res. 1988;23(1):5–8.PubMedCrossRef
82.
Zurück zum Zitat Grunwald JE et al. Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology. 1984;91(12):1447–52.PubMedCrossRef Grunwald JE et al. Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. Ophthalmology. 1984;91(12):1447–52.PubMedCrossRef
83.
Zurück zum Zitat Hammer M et al. Retinal vessel oxygen saturation under flicker light stimulation in patients with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012;53(7):4063–8.PubMedCrossRef Hammer M et al. Retinal vessel oxygen saturation under flicker light stimulation in patients with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012;53(7):4063–8.PubMedCrossRef
84.
Zurück zum Zitat Yu DY et al. Intraretinal oxygen distribution in the rat with graded systemic hyperoxia and hypercapnia. Invest Ophthalmol Vis Sci. 1999;40(9):2082–7.PubMed Yu DY et al. Intraretinal oxygen distribution in the rat with graded systemic hyperoxia and hypercapnia. Invest Ophthalmol Vis Sci. 1999;40(9):2082–7.PubMed
85.
Zurück zum Zitat Lange CA et al. Intraocular oxygen distribution in advanced proliferative diabetic retinopathy. Am J Ophthalmol. 2011;152(3):406–412.e3.PubMed Lange CA et al. Intraocular oxygen distribution in advanced proliferative diabetic retinopathy. Am J Ophthalmol. 2011;152(3):406–412.e3.PubMed
86.
Zurück zum Zitat Holekamp NM, Shui YB, Beebe D. Lower intraocular oxygen tension in diabetic patients: possible contribution to decreased incidence of nuclear sclerotic cataract. Am J Ophthalmol. 2006;141(6):1027–32.PubMedCrossRef Holekamp NM, Shui YB, Beebe D. Lower intraocular oxygen tension in diabetic patients: possible contribution to decreased incidence of nuclear sclerotic cataract. Am J Ophthalmol. 2006;141(6):1027–32.PubMedCrossRef
88.
Zurück zum Zitat Nagaoka T et al. Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol. 2004;88(8):1060–3.PubMedCentralPubMedCrossRef Nagaoka T et al. Alteration of choroidal circulation in the foveal region in patients with type 2 diabetes. Br J Ophthalmol. 2004;88(8):1060–3.PubMedCentralPubMedCrossRef
89.
Zurück zum Zitat Movaffaghy A et al. Effect of isometric exercise on choroidal blood flow in type I diabetic patients. Klin Monatsbl Augenheilkd. 2002;219(4):299–301.PubMedCrossRef Movaffaghy A et al. Effect of isometric exercise on choroidal blood flow in type I diabetic patients. Klin Monatsbl Augenheilkd. 2002;219(4):299–301.PubMedCrossRef
90.
Zurück zum Zitat Bursell SE et al. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci. 1996;37(5):886–97.PubMed Bursell SE et al. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci. 1996;37(5):886–97.PubMed
91.
Zurück zum Zitat Feke GT et al. Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol Vis Sci. 1994;35(7):2968–75.PubMed Feke GT et al. Retinal circulatory abnormalities in type 1 diabetes. Invest Ophthalmol Vis Sci. 1994;35(7):2968–75.PubMed
92.
Zurück zum Zitat Durham JT, Herman IM. Microvascular modifications in diabetic retinopathy. Curr Diabetes Rep. 2011;11(4):253–64.CrossRef Durham JT, Herman IM. Microvascular modifications in diabetic retinopathy. Curr Diabetes Rep. 2011;11(4):253–64.CrossRef
93.
Zurück zum Zitat Skov Jensen P, Jeppesen P, Bek T. Differential diameter responses in macular and peripheral retinal arterioles may contribute to the regional distribution of diabetic retinopathy lesions. Graefes Arch Clin Exp Ophthalmol. 2011;249(3):407–12.PubMedCrossRef Skov Jensen P, Jeppesen P, Bek T. Differential diameter responses in macular and peripheral retinal arterioles may contribute to the regional distribution of diabetic retinopathy lesions. Graefes Arch Clin Exp Ophthalmol. 2011;249(3):407–12.PubMedCrossRef
94.
Zurück zum Zitat Kohner EM. The retinal blood flow in diabetes. Diabete Metab. 1993;19(5):401–4.PubMed Kohner EM. The retinal blood flow in diabetes. Diabete Metab. 1993;19(5):401–4.PubMed
95.
Zurück zum Zitat Yoshida A et al. Retinal blood flow alterations during progression of diabetic retinopathy. Arch Ophthalmol. 1983;101(2):225–7.PubMedCrossRef Yoshida A et al. Retinal blood flow alterations during progression of diabetic retinopathy. Arch Ophthalmol. 1983;101(2):225–7.PubMedCrossRef
96.
Zurück zum Zitat Cunha-Vaz JG et al. Studies on retinal blood flow. II. Diabetic retinopathy. Arch Ophthalmol. 1978;96(5):809–11.PubMedCrossRef Cunha-Vaz JG et al. Studies on retinal blood flow. II. Diabetic retinopathy. Arch Ophthalmol. 1978;96(5):809–11.PubMedCrossRef
97.
Zurück zum Zitat Bresnick GH et al. Patterns of ischemia in diabetic retinopathy. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976;81(4 Pt 1):OP694–709.PubMed Bresnick GH et al. Patterns of ischemia in diabetic retinopathy. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1976;81(4 Pt 1):OP694–709.PubMed
98.
100.
Zurück zum Zitat Leong WB, et al. Effect of obstructive sleep apnoea on diabetic retinopathy and maculopathy: a systematic review and meta-analysis. Diabet Med. 2015. doi: 10.1111/dme.12817. Leong WB, et al. Effect of obstructive sleep apnoea on diabetic retinopathy and maculopathy: a systematic review and meta-analysis. Diabet Med. 2015. doi: 10.​1111/​dme.​12817.
101.
Zurück zum Zitat Nannapaneni S, Ramar K, Surani S. Effect of obstructive sleep apnea on type 2 diabetes mellitus: a comprehensive literature review. World J Diabetes. 2013;4(6):238–44.PubMedCentralPubMedCrossRef Nannapaneni S, Ramar K, Surani S. Effect of obstructive sleep apnea on type 2 diabetes mellitus: a comprehensive literature review. World J Diabetes. 2013;4(6):238–44.PubMedCentralPubMedCrossRef
102.
Zurück zum Zitat Mason RH et al. High prevalence of sleep disordered breathing in patients with diabetic macular edema. Retina. 2012;32(9):1791–8.PubMed Mason RH et al. High prevalence of sleep disordered breathing in patients with diabetic macular edema. Retina. 2012;32(9):1791–8.PubMed
103.
Zurück zum Zitat Holfort SK, Jackson GR, Larsen M. Dark adaptation during transient hyperglycemia in type 2 diabetes. Exp Eye Res. 2010;91(5):710–4.PubMedCrossRef Holfort SK, Jackson GR, Larsen M. Dark adaptation during transient hyperglycemia in type 2 diabetes. Exp Eye Res. 2010;91(5):710–4.PubMedCrossRef
104.
Zurück zum Zitat Arden GB, Wolf JE, Tsang Y. Does dark adaptation exacerbate diabetic retinopathy? Evidence and a linking hypothesis. Vis Res. 1998;38(11):1723–9.PubMedCrossRef Arden GB, Wolf JE, Tsang Y. Does dark adaptation exacerbate diabetic retinopathy? Evidence and a linking hypothesis. Vis Res. 1998;38(11):1723–9.PubMedCrossRef
105.
Zurück zum Zitat Greenstein VC et al. Effects of early diabetic retinopathy on rod system sensitivity. Optom Vis Sci. 1993;70(1):18–23.PubMedCrossRef Greenstein VC et al. Effects of early diabetic retinopathy on rod system sensitivity. Optom Vis Sci. 1993;70(1):18–23.PubMedCrossRef
107.
108.
Zurück zum Zitat Abraham FA, Haimovitz J, Berezin M. The photopic and scotopic visual thresholds in diabetics without diabetic retinopathy. Metab Pediatr Syst Ophthalmol. 1988;11(1–2):76–7. Abraham FA, Haimovitz J, Berezin M. The photopic and scotopic visual thresholds in diabetics without diabetic retinopathy. Metab Pediatr Syst Ophthalmol. 1988;11(1–2):76–7.
109.
110.
Zurück zum Zitat Frost-Larsen K, Larsen HW. Nyctometry—a new screening method for selection of patients with simple diabetic retinopathy who are at risk of developing proliferative retinopathy. Results of a 3-year follow-up. Acta Ophthalmol (Copenh). 1983;61(3):353–61.CrossRef Frost-Larsen K, Larsen HW. Nyctometry—a new screening method for selection of patients with simple diabetic retinopathy who are at risk of developing proliferative retinopathy. Results of a 3-year follow-up. Acta Ophthalmol (Copenh). 1983;61(3):353–61.CrossRef
111.
Zurück zum Zitat Schulze DP, Freese R, Sauerwald R. Nyktometric examinations on eye function in diabetic retinopathy (author’s transl). Klin Monatsbl Augenheilkd. 1976;169(3):369–72.PubMed Schulze DP, Freese R, Sauerwald R. Nyktometric examinations on eye function in diabetic retinopathy (author’s transl). Klin Monatsbl Augenheilkd. 1976;169(3):369–72.PubMed
112.
Zurück zum Zitat Frost-Larsen K, Larsen HW. Macular recovery time recorded by nyctometry—a screening method for selection of patients who are at risk of developing proliferative diabetic retinopathy. Results of a 5-year follow-up. Acta Ophthalmol Suppl. 1985;173:39–47.PubMed Frost-Larsen K, Larsen HW. Macular recovery time recorded by nyctometry—a screening method for selection of patients who are at risk of developing proliferative diabetic retinopathy. Results of a 5-year follow-up. Acta Ophthalmol Suppl. 1985;173:39–47.PubMed
113.
Zurück zum Zitat Ewing FM et al. Seeing beyond retinopathy in diabetes: electrophysiological and psychophysical abnormalities and alterations in vision. Endocr Rev. 1998;19(4):462–76.PubMedCrossRef Ewing FM et al. Seeing beyond retinopathy in diabetes: electrophysiological and psychophysical abnormalities and alterations in vision. Endocr Rev. 1998;19(4):462–76.PubMedCrossRef
114.
115.
Zurück zum Zitat Dean FM, Arden GB, Dornhorst A. Partial reversal of protan and tritan colour defects with inhaled oxygen in insulin dependent diabetic subjects. Br J Ophthalmol. 1997;81(1):27–30.PubMedCentralPubMedCrossRef Dean FM, Arden GB, Dornhorst A. Partial reversal of protan and tritan colour defects with inhaled oxygen in insulin dependent diabetic subjects. Br J Ophthalmol. 1997;81(1):27–30.PubMedCentralPubMedCrossRef
116.
Zurück zum Zitat Greenstein VC et al. S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma. Invest Ophthalmol Vis Sci. 1989;30(8):1732–7.PubMed Greenstein VC et al. S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma. Invest Ophthalmol Vis Sci. 1989;30(8):1732–7.PubMed
117.
Zurück zum Zitat Arden G, Gunduz K, Perry S. Color vision testing with a computer graphics system: preliminary results. Doc Ophthalmol. 1988;69(2):167–74.PubMedCrossRef Arden G, Gunduz K, Perry S. Color vision testing with a computer graphics system: preliminary results. Doc Ophthalmol. 1988;69(2):167–74.PubMedCrossRef
118.
Zurück zum Zitat Holopigian K et al. Evidence for photoreceptor changes in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 1997;38(11):2355–65.PubMed Holopigian K et al. Evidence for photoreceptor changes in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 1997;38(11):2355–65.PubMed
119.
Zurück zum Zitat Cho NC et al. Selective loss of S-cones in diabetic retinopathy. Arch Ophthalmol. 2000;118(10):1393–400.PubMedCrossRef Cho NC et al. Selective loss of S-cones in diabetic retinopathy. Arch Ophthalmol. 2000;118(10):1393–400.PubMedCrossRef
120.
Zurück zum Zitat Tzekov R, Arden GB. The electroretinogram in diabetic retinopathy. Surv Ophthalmol. 1999;44(1):53–60.PubMedCrossRef Tzekov R, Arden GB. The electroretinogram in diabetic retinopathy. Surv Ophthalmol. 1999;44(1):53–60.PubMedCrossRef
121.
Zurück zum Zitat Yonemura D, Aoki T, Tsuzuki K. Electroretinogram in diabetic retinopathy. Arch Ophthalmol. 1962;68:19–24.PubMedCrossRef Yonemura D, Aoki T, Tsuzuki K. Electroretinogram in diabetic retinopathy. Arch Ophthalmol. 1962;68:19–24.PubMedCrossRef
122.
Zurück zum Zitat Tyrberg M, Ponjavic V, Lovestam-Adrian M. Multifocal electroretinography (mfERG) in insulin dependent diabetics with and without clinically apparent retinopathy. Doc Ophthalmol. 2005;110(2–3):137–43.PubMedCrossRef Tyrberg M, Ponjavic V, Lovestam-Adrian M. Multifocal electroretinography (mfERG) in insulin dependent diabetics with and without clinically apparent retinopathy. Doc Ophthalmol. 2005;110(2–3):137–43.PubMedCrossRef
123.
Zurück zum Zitat Klemp K et al. The multifocal ERG in diabetic patients without retinopathy during euglycemic clamping. Invest Ophthalmol Vis Sci. 2005;46(7):2620–6.PubMedCrossRef Klemp K et al. The multifocal ERG in diabetic patients without retinopathy during euglycemic clamping. Invest Ophthalmol Vis Sci. 2005;46(7):2620–6.PubMedCrossRef
124.
Zurück zum Zitat Bresnick GH et al. Electroretinographic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report. Arch Ophthalmol. 1984;102(9):1307–11.PubMedCrossRef Bresnick GH et al. Electroretinographic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report. Arch Ophthalmol. 1984;102(9):1307–11.PubMedCrossRef
125.
Zurück zum Zitat Simonsen SE. The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Acta Ophthalmol (Copenh). 1980;58(6):865–78.CrossRef Simonsen SE. The value of the oscillatory potential in selecting juvenile diabetics at risk of developing proliferative retinopathy. Acta Ophthalmol (Copenh). 1980;58(6):865–78.CrossRef
126.
Zurück zum Zitat Drasdo N et al. Effect of darkness on inner retinal hypoxia in diabetes. Lancet. 2002;359(9325):2251–3.PubMedCrossRef Drasdo N et al. Effect of darkness on inner retinal hypoxia in diabetes. Lancet. 2002;359(9325):2251–3.PubMedCrossRef
128.
Zurück zum Zitat Arden GB, Wolf JE Collier J, Wolff C Rosenberg M. Dark adaptation is impaired in diabetics before photopic visual losses can be seen. Can hypoxia of rods contribute to diabetic retinopathy? In: Hollyfield JG, Anderson RE, LaVail MM, editors. Retinal degenerative diseases and experimental therapy. Kluver Academic/ Plenum NY; 1999. p. 305–325. Arden GB, Wolf JE Collier J, Wolff C Rosenberg M. Dark adaptation is impaired in diabetics before photopic visual losses can be seen. Can hypoxia of rods contribute to diabetic retinopathy? In: Hollyfield JG, Anderson RE, LaVail MM, editors. Retinal degenerative diseases and experimental therapy. Kluver Academic/ Plenum NY; 1999. p. 305–325.
129.
Zurück zum Zitat Sharifipour F et al. Oxygen therapy for diabetic macular ischemia: a pilot study. Retina. 2011;31(5):937–41.PubMedCrossRef Sharifipour F et al. Oxygen therapy for diabetic macular ischemia: a pilot study. Retina. 2011;31(5):937–41.PubMedCrossRef
130.
Zurück zum Zitat Nguyen QD et al. Supplemental oxygen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci. 2004;45(2):617–24.PubMedCrossRef Nguyen QD et al. Supplemental oxygen improves diabetic macular edema: a pilot study. Invest Ophthalmol Vis Sci. 2004;45(2):617–24.PubMedCrossRef
131.
Zurück zum Zitat Wright JK, Franklin B, Zant E. Clinical case report: treatment of a central retinal vein occlusion with hyperbaric oxygen. Undersea Hyperb Med. 2007;34(5):315–9.PubMed Wright JK, Franklin B, Zant E. Clinical case report: treatment of a central retinal vein occlusion with hyperbaric oxygen. Undersea Hyperb Med. 2007;34(5):315–9.PubMed
132.
Zurück zum Zitat Chang YH et al. Hyperbaric oxygen therapy ameliorates the blood-retinal barrier breakdown in diabetic retinopathy. Clin Exp Ophthalmol. 2006;34(6):584–9.CrossRef Chang YH et al. Hyperbaric oxygen therapy ameliorates the blood-retinal barrier breakdown in diabetic retinopathy. Clin Exp Ophthalmol. 2006;34(6):584–9.CrossRef
133.
Zurück zum Zitat Barlow RB, Farell B, Khan M. Metabolic modulation of visual sensitivity. Adv Exp Med Biol. 2003;533:259–67.PubMedCrossRef Barlow RB, Farell B, Khan M. Metabolic modulation of visual sensitivity. Adv Exp Med Biol. 2003;533:259–67.PubMedCrossRef
134.
Zurück zum Zitat McFarland RA, Forbes WH. The effects of variations in the concentration of oxygen and of glucose on dark adaptation. J Gen Physiol. 1940;24(1):69–98.PubMedCentralPubMedCrossRef McFarland RA, Forbes WH. The effects of variations in the concentration of oxygen and of glucose on dark adaptation. J Gen Physiol. 1940;24(1):69–98.PubMedCentralPubMedCrossRef
135.
Zurück zum Zitat Daniele S, Daniele C. Aggravation of laser-treated diabetic cystoid macular edema after prolonged flight: a case report. Aviat Space Environ Med. 1995;66(5):440–2.PubMed Daniele S, Daniele C. Aggravation of laser-treated diabetic cystoid macular edema after prolonged flight: a case report. Aviat Space Environ Med. 1995;66(5):440–2.PubMed
136.
Zurück zum Zitat Havelius U et al. Impaired dark adaptation in polycythemia. Improvement after treatment. Acta Ophthalmol Scand. 2000;78(1):53–7.PubMedCrossRef Havelius U et al. Impaired dark adaptation in polycythemia. Improvement after treatment. Acta Ophthalmol Scand. 2000;78(1):53–7.PubMedCrossRef
137.
Zurück zum Zitat Havelius U et al. II. Improved dark adaptation after carotid endarterectomy. Evidence of a long-term ischemic penumbra? Neurology. 1997;49(5):1360–4.PubMedCrossRef Havelius U et al. II. Improved dark adaptation after carotid endarterectomy. Evidence of a long-term ischemic penumbra? Neurology. 1997;49(5):1360–4.PubMedCrossRef
138.
Zurück zum Zitat Havelius U et al. I. Impaired dark adaptation in symptomatic carotid artery disease. Neurology. 1997;49(5):1353–9.PubMedCrossRef Havelius U et al. I. Impaired dark adaptation in symptomatic carotid artery disease. Neurology. 1997;49(5):1353–9.PubMedCrossRef
139.
Zurück zum Zitat McFarland RA, Halperin MH, Niven JI. Visual thresholds as an index of the modification of the effects of anoxia by glucose. Am J Physiol. 1945;144:378–88. McFarland RA, Halperin MH, Niven JI. Visual thresholds as an index of the modification of the effects of anoxia by glucose. Am J Physiol. 1945;144:378–88.
140.
Zurück zum Zitat Ewing FM et al. Effect of acute hypoglycemia on visual information processing in adults with type 1 diabetes mellitus. Physiol Behav. 1998;64(5):653–60.PubMedCrossRef Ewing FM et al. Effect of acute hypoglycemia on visual information processing in adults with type 1 diabetes mellitus. Physiol Behav. 1998;64(5):653–60.PubMedCrossRef
141.
Zurück zum Zitat McCrimmon RJ et al. Visual information processing during controlled hypoglycaemia in humans. Brain. 1996;119(Pt 4):1277–87.PubMedCrossRef McCrimmon RJ et al. Visual information processing during controlled hypoglycaemia in humans. Brain. 1996;119(Pt 4):1277–87.PubMedCrossRef
142.
Zurück zum Zitat Barlow RB, Boudreau EA, Moore DC, Huckins SC, Lindstrom AM, Farell B. Glucose and time of day modulate human contrast sensitivity and fMRI signals from visual cortex. Invest Ophthalmol Vis Sci. 1997;38:S735. Barlow RB, Boudreau EA, Moore DC, Huckins SC, Lindstrom AM, Farell B. Glucose and time of day modulate human contrast sensitivity and fMRI signals from visual cortex. Invest Ophthalmol Vis Sci. 1997;38:S735.
143.
Zurück zum Zitat Kurtenbach A et al. Hyperoxia, hyperglycemia, and photoreceptor sensitivity in normal and diabetic subjects. Vis Neurosci. 2006;23(3–4):651–61.PubMed Kurtenbach A et al. Hyperoxia, hyperglycemia, and photoreceptor sensitivity in normal and diabetic subjects. Vis Neurosci. 2006;23(3–4):651–61.PubMed
145.
Zurück zum Zitat Rimmer T, Linsenmeier RA. Resistance of diabetic rat electroretinogram to hypoxemia. Invest Ophthalmol Vis Sci. 1993;34(12):3246–52.PubMed Rimmer T, Linsenmeier RA. Resistance of diabetic rat electroretinogram to hypoxemia. Invest Ophthalmol Vis Sci. 1993;34(12):3246–52.PubMed
146.
Zurück zum Zitat Padnick-Silver L, Linsenmeier RA. Effect of acute hyperglycemia on oxygen and oxidative metabolism in the intact cat retina. Invest Ophthalmol Vis Sci. 2003;44(2):745–50.PubMedCrossRef Padnick-Silver L, Linsenmeier RA. Effect of acute hyperglycemia on oxygen and oxidative metabolism in the intact cat retina. Invest Ophthalmol Vis Sci. 2003;44(2):745–50.PubMedCrossRef
147.
Zurück zum Zitat van Dijk HW et al. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009;50(7):3404–9.PubMedCentralPubMedCrossRef van Dijk HW et al. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009;50(7):3404–9.PubMedCentralPubMedCrossRef
148.
Zurück zum Zitat Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest. 1998 Aug 15;102(4):783–91. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest. 1998 Aug 15;102(4):783–91.
149.
Zurück zum Zitat Mordant DJ et al. Oxygen saturation measurements of the retinal vasculature in treated asymmetrical primary open-angle glaucoma using hyperspectral imaging. Eye (Lond). 2014;28(10):1190–200.CrossRef Mordant DJ et al. Oxygen saturation measurements of the retinal vasculature in treated asymmetrical primary open-angle glaucoma using hyperspectral imaging. Eye (Lond). 2014;28(10):1190–200.CrossRef
150.
Zurück zum Zitat Ramsey DJ, Ripps H, Qian H. An electrophysiological study of retinal function in the diabetic female rat. Invest Ophthalmol Vis Sci. 2006;47(11):5116–24.PubMedCrossRef Ramsey DJ, Ripps H, Qian H. An electrophysiological study of retinal function in the diabetic female rat. Invest Ophthalmol Vis Sci. 2006;47(11):5116–24.PubMedCrossRef
151.
Zurück zum Zitat Tahara K, Matsuura T, Otori T. Diagnostic evaluation of diabetic retinopathy by 30-Hz flicker electroretinography. Jpn J Ophthalmol. 1993;37(2):204–10.PubMed Tahara K, Matsuura T, Otori T. Diagnostic evaluation of diabetic retinopathy by 30-Hz flicker electroretinography. Jpn J Ophthalmol. 1993;37(2):204–10.PubMed
152.
Zurück zum Zitat Ghirlanda G et al. Detection of inner retina dysfunction by steady-state focal electroretinogram pattern and flicker in early IDDM. Diabetes. 1991;40(9):1122–7.PubMedCrossRef Ghirlanda G et al. Detection of inner retina dysfunction by steady-state focal electroretinogram pattern and flicker in early IDDM. Diabetes. 1991;40(9):1122–7.PubMedCrossRef
153.
Zurück zum Zitat Bresnick GH, Palta M. Temporal aspects of the electroretinogram in diabetic retinopathy. Arch Ophthalmol. 1987;105(5):660–4.PubMedCrossRef Bresnick GH, Palta M. Temporal aspects of the electroretinogram in diabetic retinopathy. Arch Ophthalmol. 1987;105(5):660–4.PubMedCrossRef
154.
Zurück zum Zitat Sleightholm MA et al. Diabetic retinopathy: II. Assessment of severity and progression from fluorescein angiograms. J Diabet Complicat. 1988;2(3):117–20.CrossRef Sleightholm MA et al. Diabetic retinopathy: II. Assessment of severity and progression from fluorescein angiograms. J Diabet Complicat. 1988;2(3):117–20.CrossRef
155.
Zurück zum Zitat Jorgensen CM, Hardarson SH, Bek T. The oxygen saturation in retinal vessels from diabetic patients depends on the severity and type of vision-threatening retinopathy. Acta Ophthalmol. 2014;92(1):34–9.PubMedCrossRef Jorgensen CM, Hardarson SH, Bek T. The oxygen saturation in retinal vessels from diabetic patients depends on the severity and type of vision-threatening retinopathy. Acta Ophthalmol. 2014;92(1):34–9.PubMedCrossRef
156.
Zurück zum Zitat Hsu SC, Molday RS. Glycolytic enzymes and a GLUT-1 glucose transporter in the outer segments of rod and cone photoreceptor cells. J Biol Chem. 1991;266(32):21745–52.PubMed Hsu SC, Molday RS. Glycolytic enzymes and a GLUT-1 glucose transporter in the outer segments of rod and cone photoreceptor cells. J Biol Chem. 1991;266(32):21745–52.PubMed
157.
Zurück zum Zitat Hsu SC, Molday RS. Glucose metabolism in photoreceptor outer segments. Its role in phototransduction and in NADPH-requiring reactions. J Biol Chem. 1994;269(27):17954–9.PubMed Hsu SC, Molday RS. Glucose metabolism in photoreceptor outer segments. Its role in phototransduction and in NADPH-requiring reactions. J Biol Chem. 1994;269(27):17954–9.PubMed
158.
Zurück zum Zitat Panfoli I et al. Extra-mitochondrial aerobic metabolism in retinal rod outer segments: new perspectives in retinopathies. Med Hypotheses. 2012;78(4):423–7.PubMedCrossRef Panfoli I et al. Extra-mitochondrial aerobic metabolism in retinal rod outer segments: new perspectives in retinopathies. Med Hypotheses. 2012;78(4):423–7.PubMedCrossRef
159.
Zurück zum Zitat Winkler BS. Glycolytic and oxidative metabolism in relation to retinal function. J Gen Physiol. 1981;77(6):667–92.PubMedCrossRef Winkler BS. Glycolytic and oxidative metabolism in relation to retinal function. J Gen Physiol. 1981;77(6):667–92.PubMedCrossRef
160.
Zurück zum Zitat Ramsey DJ, Ramsey KM, Vavvas DG. Genetic advances in ophthalmology: the role of melanopsin-expressing, intrinsically photosensitive retinal ganglion cells in the circadian organization of the visual system. Semin Ophthalmol. 2013;28(5–6):406–21.PubMedCrossRef Ramsey DJ, Ramsey KM, Vavvas DG. Genetic advances in ophthalmology: the role of melanopsin-expressing, intrinsically photosensitive retinal ganglion cells in the circadian organization of the visual system. Semin Ophthalmol. 2013;28(5–6):406–21.PubMedCrossRef
161.
Zurück zum Zitat Arden GB. The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment. Br J Ophthalmol. 2001;85(3):366–70.PubMedCentralPubMedCrossRef Arden GB. The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment. Br J Ophthalmol. 2001;85(3):366–70.PubMedCentralPubMedCrossRef
162.
Zurück zum Zitat Holmes-Walker DJ, Mitchell P, Boyages SC. Does mitochondrial genome mutation in subjects with maternally inherited diabetes and deafness decrease severity of diabetic retinopathy? Diabet Med. 1998;15(11):946–52.PubMedCrossRef Holmes-Walker DJ, Mitchell P, Boyages SC. Does mitochondrial genome mutation in subjects with maternally inherited diabetes and deafness decrease severity of diabetic retinopathy? Diabet Med. 1998;15(11):946–52.PubMedCrossRef
163.
Zurück zum Zitat Smith PR et al. Pigmentary retinal dystrophy and the syndrome of maternally inherited diabetes and deafness caused by the mitochondrial DNA 3243 tRNA(Leu) A to G mutation. Ophthalmology. 1999;106(6):1101–8.PubMedCrossRef Smith PR et al. Pigmentary retinal dystrophy and the syndrome of maternally inherited diabetes and deafness caused by the mitochondrial DNA 3243 tRNA(Leu) A to G mutation. Ophthalmology. 1999;106(6):1101–8.PubMedCrossRef
164.
Zurück zum Zitat Pournaras CJ et al. Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs. Ophthalmology. 1990;97(10):1329–33.PubMedCrossRef Pournaras CJ et al. Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs. Ophthalmology. 1990;97(10):1329–33.PubMedCrossRef
165.
Zurück zum Zitat Frank RN. Visual fields and electroretinography following extensive photocoagulation. Arch Ophthalmol. 1975;93(8):591–8.PubMedCrossRef Frank RN. Visual fields and electroretinography following extensive photocoagulation. Arch Ophthalmol. 1975;93(8):591–8.PubMedCrossRef
166.
Zurück zum Zitat Laatikainen L. Preliminary report on effect of retinal panphotocoagulation on rubeosis iridis and neovascular glaucoma. Br J Ophthalmol. 1977;61(4):278–84.PubMedCentralPubMedCrossRef Laatikainen L. Preliminary report on effect of retinal panphotocoagulation on rubeosis iridis and neovascular glaucoma. Br J Ophthalmol. 1977;61(4):278–84.PubMedCentralPubMedCrossRef
167.
Zurück zum Zitat Haut J et al. Treatment of diabetic retinopathy by centripetal pan-retinal photocoagulation with the argon laser. Arch Ophtalmol Rev Gen Ophtalmol. 1975;35(12):951–60.PubMed Haut J et al. Treatment of diabetic retinopathy by centripetal pan-retinal photocoagulation with the argon laser. Arch Ophtalmol Rev Gen Ophtalmol. 1975;35(12):951–60.PubMed
168.
Zurück zum Zitat Plumb AP et al. A comparative trial of xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy. Br J Ophthalmol. 1982;66(4):213–8.PubMedCentralPubMedCrossRef Plumb AP et al. A comparative trial of xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy. Br J Ophthalmol. 1982;66(4):213–8.PubMedCentralPubMedCrossRef
169.
Zurück zum Zitat Alder VA, Cringle SJ, Brown M. The effect of regional retinal photocoagulation on vitreal oxygen tension. Invest Ophthalmol Vis Sci. 1987;28(7):1078–85.PubMed Alder VA, Cringle SJ, Brown M. The effect of regional retinal photocoagulation on vitreal oxygen tension. Invest Ophthalmol Vis Sci. 1987;28(7):1078–85.PubMed
170.
Zurück zum Zitat Stefansson E et al. Panretinal photocoagulation and retinal oxygenation in normal and diabetic cats. Am J Ophthalmol. 1986;101(6):657–64.PubMedCrossRef Stefansson E et al. Panretinal photocoagulation and retinal oxygenation in normal and diabetic cats. Am J Ophthalmol. 1986;101(6):657–64.PubMedCrossRef
171.
Zurück zum Zitat Stefansson E, Landers 3rd MB, Wolbarsht ML. Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomy. Trans Am Ophthalmol Soc. 1981;79:307–34.PubMedCentralPubMed Stefansson E, Landers 3rd MB, Wolbarsht ML. Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomy. Trans Am Ophthalmol Soc. 1981;79:307–34.PubMedCentralPubMed
172.
Zurück zum Zitat Novack RL, Stefansson E, Hatchell DL. The effect of photocoagulation on the oxygenation and ultrastructure of avascular retina. Exp Eye Res. 1990;50(3):289–96.PubMedCrossRef Novack RL, Stefansson E, Hatchell DL. The effect of photocoagulation on the oxygenation and ultrastructure of avascular retina. Exp Eye Res. 1990;50(3):289–96.PubMedCrossRef
173.
Zurück zum Zitat Molnar I et al. Effect of laser photocoagulation on oxygenation of the retina in miniature pigs. Invest Ophthalmol Vis Sci. 1985;26(10):1410–4.PubMed Molnar I et al. Effect of laser photocoagulation on oxygenation of the retina in miniature pigs. Invest Ophthalmol Vis Sci. 1985;26(10):1410–4.PubMed
174.••
Zurück zum Zitat Sivaprasad S et al. A multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA): study protocol for a randomised controlled trial. Trials. 2014;15:458. The outcomes of this study will provide insight into whether light-masks aimed at preventing dark-adaptation can prevent the progression of early DME. Enrollment for this trial has completed and the results from ~300 patients randomized to light-masks or observation are expected within two years time.PubMedCentralPubMedCrossRef Sivaprasad S et al. A multicentre phase III randomised controlled single-masked clinical trial evaluating the clinical efficacy and safety of light-masks at preventing dark-adaptation in the treatment of early diabetic macular oedema (CLEOPATRA): study protocol for a randomised controlled trial. Trials. 2014;15:458. The outcomes of this study will provide insight into whether light-masks aimed at preventing dark-adaptation can prevent the progression of early DME. Enrollment for this trial has completed and the results from ~300 patients randomized to light-masks or observation are expected within two years time.PubMedCentralPubMedCrossRef
175.•
Zurück zum Zitat McKeague C et al. Low-level night-time light therapy for age-related macular degeneration (ALight): study protocol for a randomized controlled trial. Trials. 2014;15:246. This phase I/IIa clinical trial of light at night examines the prevention of dark adaptation as a means of arresting the progression to neovascular age related macular degeneration (AMD). The hypothesis is that choroidal perfusion abnormalities promote hypoxia in AMD, which is exacerbated by the dark current.PubMedCentralPubMedCrossRef McKeague C et al. Low-level night-time light therapy for age-related macular degeneration (ALight): study protocol for a randomized controlled trial. Trials. 2014;15:246. This phase I/IIa clinical trial of light at night examines the prevention of dark adaptation as a means of arresting the progression to neovascular age related macular degeneration (AMD). The hypothesis is that choroidal perfusion abnormalities promote hypoxia in AMD, which is exacerbated by the dark current.PubMedCentralPubMedCrossRef
176.
Zurück zum Zitat Figueiro MG, Plitnick B, Rea MS. Pulsing blue light through closed eyelids: effects on acute melatonin suppression and phase shifting of dim light melatonin onset. Nat Sci Sleep. 2014;6:149–56.PubMedCentralPubMedCrossRef Figueiro MG, Plitnick B, Rea MS. Pulsing blue light through closed eyelids: effects on acute melatonin suppression and phase shifting of dim light melatonin onset. Nat Sci Sleep. 2014;6:149–56.PubMedCentralPubMedCrossRef
177.
Zurück zum Zitat Troxler IPV. Uber das Verschwinden gegeb- ener Gegenstande innerhalb unseres Gesichtskreises. In: Schmidt JHJA, editor. Ophthalmologische Bibliothek. Jena: Fromann; 1804. p. 1–119. Troxler IPV. Uber das Verschwinden gegeb- ener Gegenstande innerhalb unseres Gesichtskreises. In: Schmidt JHJA, editor. Ophthalmologische Bibliothek. Jena: Fromann; 1804. p. 1–119.
178.
Zurück zum Zitat Ando K, Kripke DF. Light attenuation by the human eyelid. Biol Psychiatry. 1996;39(1):22–5.PubMedCrossRef Ando K, Kripke DF. Light attenuation by the human eyelid. Biol Psychiatry. 1996;39(1):22–5.PubMedCrossRef
179.
Zurück zum Zitat Winn B et al. Factors affecting light-adapted pupil size in normal human subjects. Invest Ophthalmol Vis Sci. 1994;35(3):1132–7.PubMed Winn B et al. Factors affecting light-adapted pupil size in normal human subjects. Invest Ophthalmol Vis Sci. 1994;35(3):1132–7.PubMed
180.
Zurück zum Zitat Robinson J, Bayliss SC, Fielder AR. Transmission of light across the adult and neonatal eyelid in vivo. Vis Res. 1991;31(10):1837–40.PubMedCrossRef Robinson J, Bayliss SC, Fielder AR. Transmission of light across the adult and neonatal eyelid in vivo. Vis Res. 1991;31(10):1837–40.PubMedCrossRef
181.
Zurück zum Zitat Moseley MJ, Bayliss SC, Fielder AR. Light transmission through the human eyelid: in vivo measurement. Ophthalmic Physiol Opt. 1988;8(2):229–30.PubMedCrossRef Moseley MJ, Bayliss SC, Fielder AR. Light transmission through the human eyelid: in vivo measurement. Ophthalmic Physiol Opt. 1988;8(2):229–30.PubMedCrossRef
182.
Zurück zum Zitat Wilhelm BJ et al. Pupil response components: studies in patients with Parinaud’s syndrome. Brain. 2002;125(Pt 10):2296–307.PubMedCrossRef Wilhelm BJ et al. Pupil response components: studies in patients with Parinaud’s syndrome. Brain. 2002;125(Pt 10):2296–307.PubMedCrossRef
183.
Zurück zum Zitat Rechtschaffen A. Current perspectives on the function of sleep. Perspect Biol Med. 1998;41(3):359–90.PubMedCrossRef Rechtschaffen A. Current perspectives on the function of sleep. Perspect Biol Med. 1998;41(3):359–90.PubMedCrossRef
184.
Zurück zum Zitat Luttrull JK, Dorin G. Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review. Curr Diabetes Rev. 2012;8(4):274–84.PubMedCentralPubMedCrossRef Luttrull JK, Dorin G. Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review. Curr Diabetes Rev. 2012;8(4):274–84.PubMedCentralPubMedCrossRef
185.
Zurück zum Zitat Sivaprasad S et al. Micropulsed diode laser therapy: evolution and clinical applications. Surv Ophthalmol. 2010;55(6):516–30.PubMedCrossRef Sivaprasad S et al. Micropulsed diode laser therapy: evolution and clinical applications. Surv Ophthalmol. 2010;55(6):516–30.PubMedCrossRef
186.
Zurück zum Zitat Taban M et al. Efficacy of verteporfin photodynamic therapy on laser-induced choroidal neovascularization and the ancillary effect on diabetic microvasculopathy. Curr Eye Res. 2004;28(4):291–5.PubMedCrossRef Taban M et al. Efficacy of verteporfin photodynamic therapy on laser-induced choroidal neovascularization and the ancillary effect on diabetic microvasculopathy. Curr Eye Res. 2004;28(4):291–5.PubMedCrossRef
187.
Zurück zum Zitat Ladd BS et al. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy. Am J Ophthalmol. 2001;132(5):659–67.PubMedCrossRef Ladd BS et al. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with diabetic retinopathy. Am J Ophthalmol. 2001;132(5):659–67.PubMedCrossRef
188.
Zurück zum Zitat Roelandts R. The history of phototherapy: something new under the sun? J Am Acad Dermatol. 2002;46(6):926–30.PubMedCrossRef Roelandts R. The history of phototherapy: something new under the sun? J Am Acad Dermatol. 2002;46(6):926–30.PubMedCrossRef
189.
Zurück zum Zitat Ivandic BT, Ivandic T. Low-level laser therapy improves vision in a patient with retinitis pigmentosa. Photomed Laser Surg. 2014;32(3):181–4.PubMedCrossRef Ivandic BT, Ivandic T. Low-level laser therapy improves vision in a patient with retinitis pigmentosa. Photomed Laser Surg. 2014;32(3):181–4.PubMedCrossRef
190.••
Zurück zum Zitat Calaza KC, et al. Mitochondrial decline precedes phenotype development in the complement factor H mouse model of retinal degeneration but can be corrected by near infrared light. Neurobiol Aging. 2015;36(10):2869–76. Exposure to near-infrared light may improve mitochondrial function thereby increasing ATP production countering the effects of aging and diabetes where oxidative stress and inflammation impair cellular metabolism. Calaza KC, et al. Mitochondrial decline precedes phenotype development in the complement factor H mouse model of retinal degeneration but can be corrected by near infrared light. Neurobiol Aging. 2015;36(10):2869–76. Exposure to near-infrared light may improve mitochondrial function thereby increasing ATP production countering the effects of aging and diabetes where oxidative stress and inflammation impair cellular metabolism.
191.
Zurück zum Zitat Gkotsi D et al. Recharging mitochondrial batteries in old eyes. Near infra-red increases ATP. Exp Eye Res. 2014;122:50–3.PubMedCrossRef Gkotsi D et al. Recharging mitochondrial batteries in old eyes. Near infra-red increases ATP. Exp Eye Res. 2014;122:50–3.PubMedCrossRef
192.
Zurück zum Zitat Kokkinopoulos I et al. Age-related retinal inflammation is reduced by 670 nm light via increased mitochondrial membrane potential. Neurobiol Aging. 2013;34(2):602–9.PubMedCrossRef Kokkinopoulos I et al. Age-related retinal inflammation is reduced by 670 nm light via increased mitochondrial membrane potential. Neurobiol Aging. 2013;34(2):602–9.PubMedCrossRef
193.
Zurück zum Zitat Natoli R et al. 670 nm photobiomodulation as a novel protection against retinopathy of prematurity: evidence from oxygen induced retinopathy models. PLoS One. 2013;8(8):e72135.PubMedCentralPubMedCrossRef Natoli R et al. 670 nm photobiomodulation as a novel protection against retinopathy of prematurity: evidence from oxygen induced retinopathy models. PLoS One. 2013;8(8):e72135.PubMedCentralPubMedCrossRef
194.
195.•
Zurück zum Zitat Tang J et al. Low-intensity far-red light inhibits early lesions that contribute to diabetic retinopathy: in vivo and in vitro. Invest Ophthalmol Vis Sci. 2013;54(5):3681–90. This study examined the effect of PBM treatment with far-red/near-infrared light (670 nm) in streptozotocin (STZ)-diabetic rats and in various commercially available cell lines exposed to hyperglycemic stress. In the animal model, abnormalities in leukostasis and expression of ICAM-1 were largely prevented; in cell culture, superoxide production, inflammatory biomarker expression, and cell death were all reduced. An important caveat to this work is that an albino animal model was utilized, which may significantly impact the properties of light exposure.PubMedCentralPubMedCrossRef Tang J et al. Low-intensity far-red light inhibits early lesions that contribute to diabetic retinopathy: in vivo and in vitro. Invest Ophthalmol Vis Sci. 2013;54(5):3681–90. This study examined the effect of PBM treatment with far-red/near-infrared light (670 nm) in streptozotocin (STZ)-diabetic rats and in various commercially available cell lines exposed to hyperglycemic stress. In the animal model, abnormalities in leukostasis and expression of ICAM-1 were largely prevented; in cell culture, superoxide production, inflammatory biomarker expression, and cell death were all reduced. An important caveat to this work is that an albino animal model was utilized, which may significantly impact the properties of light exposure.PubMedCentralPubMedCrossRef
196.••
Zurück zum Zitat Tang J, Herda AA, Kern TS. Photobiomodulation in the treatment of patients with non-center-involving diabetic macular oedema. Br J Ophthalmol. 2014;98(8):1013–5. Twice daily PBM treatment for only 80 seconds per treatment caused a reduction in focal retinal thickening in all 4 treated eyes in this study. Future studies of far-red/near-infrared phototherapy need evaluate the spectral and dose sensitivity of this effect.PubMedCentralPubMedCrossRef Tang J, Herda AA, Kern TS. Photobiomodulation in the treatment of patients with non-center-involving diabetic macular oedema. Br J Ophthalmol. 2014;98(8):1013–5. Twice daily PBM treatment for only 80 seconds per treatment caused a reduction in focal retinal thickening in all 4 treated eyes in this study. Future studies of far-red/near-infrared phototherapy need evaluate the spectral and dose sensitivity of this effect.PubMedCentralPubMedCrossRef
197.
Zurück zum Zitat Karu T. Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B. 1999;49(1):1–17.PubMedCrossRef Karu T. Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B. 1999;49(1):1–17.PubMedCrossRef
198.•
Zurück zum Zitat Begum R et al. Treatment with 670 nm light up regulates cytochrome C oxidase expression and reduces inflammation in an age-related macular degeneration model. PLoS One. 2013;8(2):e57828. This study examined the effect of PBM treatment with far-red/near-infrared light (670 nm) in the complement factor H knockout (CFH(−/−)) mouse model of AMD. A significant reduction in complement component C3, an inflammatory marker, was observed in the outer retina. The authors propose that environmental exposure to PBM may be effective in reducing inflammation in AMD and suggest COX activation as the mechanism.PubMedCentralPubMedCrossRef Begum R et al. Treatment with 670 nm light up regulates cytochrome C oxidase expression and reduces inflammation in an age-related macular degeneration model. PLoS One. 2013;8(2):e57828. This study examined the effect of PBM treatment with far-red/near-infrared light (670 nm) in the complement factor H knockout (CFH(−/−)) mouse model of AMD. A significant reduction in complement component C3, an inflammatory marker, was observed in the outer retina. The authors propose that environmental exposure to PBM may be effective in reducing inflammation in AMD and suggest COX activation as the mechanism.PubMedCentralPubMedCrossRef
199.
Zurück zum Zitat Poyton RO, Ball KA. Therapeutic photobiomodulation: nitric oxide and a novel function of mitochondrial cytochrome C oxidase. Discov Med. 2011;11(57):154–9.PubMed Poyton RO, Ball KA. Therapeutic photobiomodulation: nitric oxide and a novel function of mitochondrial cytochrome C oxidase. Discov Med. 2011;11(57):154–9.PubMed
200.
Zurück zum Zitat Yeager RL et al. Melatonin as a principal component of red light therapy. Med Hypotheses. 2007;69(2):372–6.PubMedCrossRef Yeager RL et al. Melatonin as a principal component of red light therapy. Med Hypotheses. 2007;69(2):372–6.PubMedCrossRef
201.
Zurück zum Zitat Purves D, Williams SM. Neuroscience. Sunderland: Sinauer Associates; 2001. p. xviii, 681, 16, 3, 25 p. Purves D, Williams SM. Neuroscience. Sunderland: Sinauer Associates; 2001. p. xviii, 681, 16, 3, 25 p.
202.
Zurück zum Zitat Bone RA, Landrum JT, Tarsis SL. Preliminary identification of the human macular pigment. Vis Res. 1985;25(11):1531–5.PubMedCrossRef Bone RA, Landrum JT, Tarsis SL. Preliminary identification of the human macular pigment. Vis Res. 1985;25(11):1531–5.PubMedCrossRef
203.
Zurück zum Zitat Geeraets WJ et al. The loss of light energy in retina and choroid. Arch Ophthalmol. 1960;64:606–15.PubMedCrossRef Geeraets WJ et al. The loss of light energy in retina and choroid. Arch Ophthalmol. 1960;64:606–15.PubMedCrossRef
204.
Metadaten
Titel
Hypoxia and Dark Adaptation in Diabetic Retinopathy: Interactions, Consequences, and Therapy
verfasst von
David J. Ramsey
G. B. Arden
Publikationsdatum
01.12.2015
Verlag
Springer US
Erschienen in
Current Diabetes Reports / Ausgabe 12/2015
Print ISSN: 1534-4827
Elektronische ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-015-0686-2

Weitere Artikel der Ausgabe 12/2015

Current Diabetes Reports 12/2015 Zur Ausgabe

Health Care Delivery Systems and Implementation in Diabetes (EB Morton-Eggleston, Section Editor)

Health Systems Approaches to Diabetes Screening and Prevention in Women with a History of Gestational Diabetes

Health Care Delivery Systems and Implementation in Diabetes (EB Morton-Eggleston, Section Editor)

Mobile Phone and Smartphone Technologies for Diabetes Care and Self-Management

Macrovascular Complications in Diabetes (VR Aroda and A Getaneh, Section Editors)

Hypoglycemia and Cardiovascular Disease: Lessons from Outcome Studies

Diabetes Epidemiology (NM Maruthur, Section Editor)

Betatrophin in Diabetes Mellitus: the Epidemiological Evidence in Humans

Diabetes Epidemiology (NM Maruthur, Section Editor)

Novel Risk Factors for Type 2 Diabetes in African-Americans

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.